查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1225339

mRNA 疫苗和 mRNA 治療市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

到 2022 年，全球 mRNA 疫苗和療法的市場規模將達到 561 億美元。 展望未來，IMARC Group 預計到 2028 年將達到 662 億美元，2023 年至 2028 年的增長率 (CAGR) 為 2.9%。

信使核糖核酸 (mRNA) 是指基因組中的單個蛋白質編碼基因，是細胞內蛋白質合成的基礎。 mRNA 疫苗和治療劑結合了理想的免疫學特性，並在實驗室中使用哺乳動物細胞製備。 常見的疫苗和療法包括自我擴增、非複制、體內自我複制和體外樹突細胞非複制 mRNA。 這些被注入體內，激活檢測病毒的免疫傳感器，並在細胞中產生病毒抗原蛋白。 這可以改善 B 細胞和 T 細胞的反應並增強身體的免疫力。

糖尿病、結核病、癌症和心血管疾病 (CVD) 等疾病患病率上升是推動市場增長的關鍵因素之一。 對埃博拉、流感和人類免疫缺陷病毒 (HIV) 等病毒感染的治療藥物和疫苗的需求不斷增長，也推動了市場增長。 與常規藥物相比，mRNA 疫苗和治療劑對病原體更有效，具有更高的效力和免疫原性，並且正在使用成本效益相對較高的先進技術進行開發。 此外，用於體內全身遞送mRNA的脂質納米顆粒製劑的改進也為市場帶來了光明的前景。 製藥公司正在投資 mRNA 技術，因為它允許將多個分子組合成治療藥物，這也是主要的增長動力。 其他因素，如生物技術領域的廣泛研發 (R&D) 活動和醫療保健技術的改進，預計將進一步推動市場。

主要市場細分

  • 在其 mRNA 疫苗和治療藥物的全球市場報告中，IMARC Group 提供了 2023 年至 2028 年全球、區域和國家層面的預測，以及每個子細分市場的主要趨勢分析。 該報告根據疫苗類型、治療類型、疫苗生產、應用、最終用戶等對市場進行分類。

按疫苗類型分類

  • 基於自擴增 mRNA 的疫苗
  • 傳統的未擴增的基於 mRNA 的疫苗

按治療類型細分

  • 生物基因疫苗
  • 基因療法
  • 基因轉移
  • 細胞療法
  • 單克隆抗體
  • 其他

疫苗生產細目

  • 內部
  • 外包

按應用細分

  • 癌症
  • 感染
  • 基因編輯
  • 蛋白質替代品

最終用戶細分

  • 醫院和診所
  • 研究所
  • 其他

按地區劃分

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

內容

第一章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據來源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第四章介紹

  • 概覽
  • 主要行業趨勢

第 5 章 mRNA 疫苗和治療學簡介

  • mRNA 疫苗和藥物開發的歷史
  • 慢性病和主要傳染病的患病率和患病率
  • 通過 mRNA 疫苗/治療劑進行預防和治療
    • mRNA 修飾
    • mRNA 效率
    • mRNA 疫苗的佐劑、激活劑和載體技術
    • 使用 mRNA 的蛋白質/抗體藥物載體

第 6 章 mRNA 疫苗和治療藥物的全球市場

  • 市場潛力概覽
  • 市場潛力
  • COVID-19 的影響
  • 研發中的 mRNA 疫苗

第 7 章疫苗類型市場細分

  • 基於自擴增 mRNA 的疫苗
  • 傳統的未擴增的基於 mRNA 的疫苗

第 8 章按治療類型劃分的市場細分

  • 基因治療
  • 單克隆抗體
  • 基因轉錄
  • 細胞療法
  • 生物技術疫苗
  • 其他

第 9 章疫苗製造的市場細分

  • 內部
  • 外包

第 10 章按應用劃分的市場細分

  • 癌症
  • 感染
  • 基因編輯
  • 蛋白質替代品

第 11 章最終用戶的市場細分

  • 醫院和診所
  • 研究所
  • 其他

第 12 章區域市場細分

  • 北美
    • 按國家/地區劃分的市場細分
      • 美國
      • 加拿大
  • 歐洲
    • 按國家/地區劃分的市場細分
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 俄羅斯
      • 其他
  • 亞太地區
    • 按國家/地區劃分的市場細分
      • 日本
      • 中國
      • 澳大利亞
      • 韓國
      • 印度
      • 印度尼西亞
      • 其他
  • 拉丁美洲
    • 按國家/地區劃分的市場細分
      • 巴西
      • 墨西哥
      • 其他
  • 中東和非洲
    • 按國家/地區劃分的市場細分

第 13 章 SWOT 分析

  • 概覽
  • 強度
  • 弱點
  • 機會
  • 威脅

第14章價值鏈分析

第15章波特五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第16章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Arcturus Therapeutics, Inc.
    • BioNTech SE
    • CureVac AG
    • eTheRNA immunotherapies NV
    • ethris GmbH
    • GlaxoSmithKline PLC
    • Moderna Therapeutics Inc.
    • Translate Bio Inc.
    • Argos Therapeutics, Inc.
    • Sangamo Therapeutics Inc.
    • Pfizer Inc.
Product Code: SR1423A180_Report

The global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 66.2 Billion by 2028, exhibiting a growth rate (CAGR) of 2.9% during 2023-2028.

Messenger Ribonucleic Acid (mRNA) refers to a single protein-coding gene in the genome that acts as a basis for protein synthesis within the cells. mRNA vaccines and therapeutics combine the desirable immunological properties and are prepared in laboratories using mammalian cells. Some of the common types of vaccines and therapeutics include self-amplifying, non-replicating, in vivo self-replicating and in vitro dendritic cell non-replicating mRNA. They are injected into the body to trigger virus-detecting immune sensors and produce viral antigen proteins within the cells. This aids in enhancing the body's immunity by improving B- and T-cell responses.

The rising prevalence of medical ailments, such as diabetes, tuberculosis, cancer and cardiovascular diseases (CVDs), is one of the key factors driving the growth of the market. The increasing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections is also providing a boost to the market growth. In comparison to conventional medicines, mRNA vaccines and therapeutics are developed using advanced technologies that are more effective against pathogens, have higher potency, enhanced immunogenicity and are relatively more cost-effective. Additionally, improvements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market. Pharmaceutical companies are investing in mRNA technologies as they can combine multiple molecules into a therapeutic medicine, which is acting as another major growth-inducing factor. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with improvements in the healthcare technologies, are projected to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global mRNA vaccines and therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, treatment type, vaccine manufacturing, application and end-user.

Breakup by Vaccine Type:

  • Self-amplifying mRNA-Based Vaccines
  • Conventional Non-Amplifying mRNA-Based Vaccines

Breakup by Treatment Type:

  • Bioengineered Vaccine
  • Gene Therapy
  • Gene Transcription
  • Cell Therapy
  • Monoclonal Antibody
  • Others

Breakup by Vaccine Manufacturing:

  • In-House
  • Out-Sourced

Breakup by Application:

  • Cancer
  • Infectious Disease
  • Gene Editing
  • Protein Replacement

Breakup by End-User:

  • Hospitals and Clinics
  • Research Organizations
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined with some of the key players being Arcturus Therapeutics Inc., BioNTech SE, CureVac AG, eTheRNA immunotherapies NV, ethris GmbH, GlaxoSmithKline PLC, Moderna Therapeutics Inc., Translate Bio Inc., Argos Therapeutics, Inc., Sangamo Therapeutics Inc. and Pfizer Inc, etc.
  • Key Questions Answered in This Report
  • 1. What was the size of the global mRNA vaccines and therapeutics market in 2022?
  • 2. What is the expected growth rate of the global mRNA vaccines and therapeutics market during 2023-2028?
  • 3. What are the key factors driving the global mRNA vaccines and therapeutics market?
  • 4. What has been the impact of COVID-19 on the global mRNA vaccines and therapeutics market?
  • 5. What is the breakup of the global mRNA vaccines and therapeutics market based on the vaccine type?
  • 6. What is the breakup of the global mRNA vaccines and therapeutics market based on the treatment type?
  • 7. What is the breakup of the global mRNA vaccines and therapeutics market based on vaccine manufacturing?
  • 8. What is the breakup of the global mRNA vaccines and therapeutics market based on the application?
  • 9. What is the breakup of the global mRNA vaccines and therapeutics market based on the end-user?
  • 10. What are the key regions in the global mRNA vaccines and therapeutics market?
  • 11. Who are the key players/companies in the global mRNA vaccines and therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Introduction to mRNA Vaccines and Therapeutics

  • 5.1 History of mRNA Vaccines and Therapeutics Development
  • 5.2 Incidence and Prevalence of Chronic Diseases and Major Infectious Diseases
  • 5.3 Prevention and Treatment Using mRNA Vaccines and Therapeutics
    • 5.3.1 mRNA Modifications
    • 5.3.2 mRNA Efficiencies
    • 5.3.3 Adjuvant/Stimulant and Carrier Technologies for mRNA-Based Vaccines
    • 5.3.4 Carriers for mRNA-Based Protein and Antibody Therapeutics

6 Global mRNA Vaccines and Therapeutics Market

  • 6.1 Market Potential Overview
  • 6.2 Market Potential
  • 6.3 Impact of COVID-19
  • 6.4 mRNA Vaccines in Pipeline

7 Market Breakup by Vaccine Type

  • 7.1 Self-amplifying mRNA-Based Vaccines
  • 7.2 Conventional Non-Amplifying mRNA-Based Vaccines

8 Market Breakup by Treatment Type

  • 8.1 Gene Therapy
  • 8.2 Monoclonal Antibody
  • 8.3 Gene Transcription
  • 8.4 Cell Therapy
  • 8.5 Bioengineered Vaccine
  • 8.6 Others

9 Market Breakup by Vaccine Manufacturing

  • 9.1 In-House
  • 9.2 Out-Sourced

10 Market Breakup by Application

  • 10.1 Cancer
  • 10.2 Infectious Disease
  • 10.3 Gene Editing
  • 10.4 Protein Replacement

11 Market Breakup by End-User

  • 11.1 Hospitals and Clinics
  • 11.2 Research Organizations
  • 11.3 Others

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 Market Breakup by Country
      • 12.1.1.1 United States
      • 12.1.1.2 Canada
  • 12.2 Europe
    • 12.2.1 Market Breakup by Country
      • 12.2.1.1 Germany
      • 12.2.1.2 United Kingdom
      • 12.2.1.3 France
      • 12.2.1.4 Italy
      • 12.2.1.5 Spain
      • 12.2.1.6 Russia
      • 12.2.1.7 Others
  • 12.3 Asia Pacific
    • 12.3.1 Market Breakup by Country
      • 12.3.1.1 Japan
      • 12.3.1.2 China
      • 12.3.1.3 Australia
      • 12.3.1.4 South Korea
      • 12.3.1.5 India
      • 12.3.1.6 Indonesia
      • 12.3.1.7 Others
  • 12.4 Latin America
    • 12.4.1 Market Breakup by Country
      • 12.4.1.1 Brazil
      • 12.4.1.2 Mexico
      • 12.4.1.3 Others
  • 12.5 Middle East and Africa
    • 12.5.1 Market Breakup by Country

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Arcturus Therapeutics, Inc.
    • 16.3.2 BioNTech SE
    • 16.3.3 CureVac AG
    • 16.3.4 eTheRNA immunotherapies NV
    • 16.3.5 ethris GmbH
    • 16.3.6 GlaxoSmithKline PLC
    • 16.3.7 Moderna Therapeutics Inc.
    • 16.3.8 Translate Bio Inc.
    • 16.3.9 Argos Therapeutics, Inc.
    • 16.3.10 Sangamo Therapeutics Inc.
    • 16.3.11 Pfizer Inc.

List of Figures

  • Figure 1: Global: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 2: Global: mRNA Vaccines and Therapeutics Market Potential (Self-amplifying mRNA-Based Vaccines): Value Trends (in Billion US$), 2023-2028
  • Figure 3: Global: mRNA Vaccines and Therapeutics Market Potential (Conventional Non-Amplifying mRNA-Based Vaccines): Value Trends (in Billion US$), 2023-2028
  • Figure 4: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Therapy): Value Trends (in Billion US$), 2023-2028
  • Figure 5: Global: mRNA Vaccines and Therapeutics Market Potential (Monoclonal Antibody): Value Trends (in Billion US$), 2023-2028
  • Figure 6: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Transcription): Value Trends (in Billion US$), 2023-2028
  • Figure 7: Global: mRNA Vaccines and Therapeutics Market Potential (Cell Therapy): Value Trends (in Billion US$), 2023-2028
  • Figure 8: Global: mRNA Vaccines and Therapeutics Market Potential (Bioengineered Vaccine): Value Trends (in Billion US$), 2023-2028
  • Figure 9: Global: mRNA Vaccines and Therapeutics Market Potential (Other Treatment Types): Value Trends (in Billion US$), 2023-2028
  • Figure 10: Global: mRNA Vaccines and Therapeutics Market Potential (In-House): Value Trends (in Billion US$), 2023-2028
  • Figure 11: Global: mRNA Vaccines and Therapeutics Market Potential (Out-Sourced): Value Trends (in Billion US$), 2023-2028
  • Figure 12: Global: mRNA Vaccines and Therapeutics Market Potential (Cancer): Value Trends (in Billion US$), 2023-2028
  • Figure 13: Global: mRNA Vaccines and Therapeutics Market Potential (Infectious Disease): Value Trends (in Billion US$), 2023-2028
  • Figure 14: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Editing): Value Trends (in Billion US$), 2023-2028
  • Figure 15: Global: mRNA Vaccines and Therapeutics Market Potential (Protein Replacement): Value Trends (in Billion US$), 2023-2028
  • Figure 16: Global: mRNA Vaccines and Therapeutics Market Potential (Hospitals and Clinics): Value Trends (in Billion US$), 2023-2028
  • Figure 17: Global: mRNA Vaccines and Therapeutics Market Potential (Research Organizations): Value Trends (in Billion US$), 2023-2028
  • Figure 18: Global: mRNA Vaccines and Therapeutics Market Potential (Other End-Users): Value Trends (in Billion US$), 2023-2028
  • Figure 19: North America: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 20: North America: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2022
  • Figure 21: United States: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 22: Canada: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 23: Europe: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 24: Europe: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2022
  • Figure 25: Germany: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 26: United Kingdom: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 27: France: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 28: Italy: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 29: Spain: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 30: Russia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 31: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 32: Asia Pacific: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 33: Asia Pacific: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2022
  • Figure 34: Japan: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 35: China: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 36: Australia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 37: South Korea: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 38: India: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 39: Indonesia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 40: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 41: Latin America: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 42: Latin America: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2022
  • Figure 43: Brazil: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 44: Mexico: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 45: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 46: Middle East and Africa: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 47: Middle East and Africa: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2022
  • Figure 48: Global: mRNA Vaccines and Therapeutics Industry: SWOT Analysis
  • Figure 49: Global: mRNA Vaccines and Therapeutics Industry: Value Chain Analysis
  • Figure 50: Global: mRNA Vaccines and Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: mRNA Vaccines and Therapeutics Market Potential: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: mRNA Vaccines and Therapeutics Market: List of Pipeline mRNA Vaccines
  • Table 3: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Vaccine Type (in Billion US$), 2023-2028
  • Table 4: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Treatment Type (in Billion US$), 2023-2028
  • Table 5: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Vaccine Manufacturing (in Billion US$), 2023-2028
  • Table 6: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Application (in Billion US$), 2023-2028
  • Table 7: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by End-User (in Billion US$), 2023-2028
  • Table 8: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Region (in Billion US$), 2023-2028
  • Table 9: Global: mRNA Vaccines and Therapeutics Market: Competitive Structure
  • Table 10: Global: mRNA Vaccines and Therapeutics Market: List of Key Players